Corneal Injuries Clinical Trial
Official title:
Peri-operative Application of EYEPROTX General Anesthesia Protective Goggles as an Effective Modality to Reduce the Incidence of Corneal Injury Post-Intubation.
NCT number | NCT03762889 |
Other study ID # | 20180875 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2019 |
Est. completion date | December 2019 |
Verified date | June 2019 |
Source | University of Miami |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized controlled trial that seeks to examine the effectiveness of Eyeprotx™ protective goggles in comparison to traditional methods against ocular injury that can occur perioperatively under general anesthesia.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2019 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients undergoing general anesthesia - Patients admitted to Jackson Memorial Hospital Exclusion Criteria: - Patients unable to communicate, for whatever reason - Patients predisposed to eye conditions - Patients with history of increased intraocular pressure - Patients with a medical history of Sicca syndrome - Patients with claustrophobia - Patients with pseudoexfoliation syndromes - Patients with a current exopthalmic condition |
Country | Name | City | State |
---|---|---|---|
United States | Jackson Memorial Hospital | Miami | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Miami |
United States,
Figueiro MG, Rea MS. Preliminary evidence that light through the eyelids can suppress melatonin and phase shift dim light melatonin onset. BMC Res Notes. 2012 May 7;5:221. doi: 10.1186/1756-0500-5-221. — View Citation
Gild WM, Posner KL, Caplan RA, Cheney FW. Eye injuries associated with anesthesia. A closed claims analysis. Anesthesiology. 1992 Feb;76(2):204-8. — View Citation
White E, Crosse MM. The aetiology and prevention of peri-operative corneal abrasions. Anaesthesia. 1998 Feb;53(2):157-61. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Usability Scale Per Operator | The anesthesiologists and nurse anesthetists working on the trial will be asked to complete a usability scale questionnaire to evaluate the effectiveness of the different variation of the goggles, such as goggles with a strap versus goggles with short sterilized adhesive tape. | This measure will be evaluated up to 6 months after the post-surgical operation. | |
Primary | Changes in Baseline Ocular Condition post-operatively | The following will be measured upon evaluation, using a numerical scale of 1 to 8, with 1 being complete absence of condition and 8 being the most severe presentation of the condition: 1. eye discomfort, 2, pain, and 3. dryness intensity, each on a numerical rating-scale of 1 to 8, The measures will be compared among the goggle, ointment, and tape groups. |
The patient's initial rating will be recorded approximately ten minutes before surgery at the point of anesthesia evaluation and will be reassessed up to 24 hours post-operatively. | |
Primary | Incidence of Ocular Complications post-operation | Incidence of corneal abrasion, conjunctivitis, MRSA infection, and direct ocular trauma will be assessed by the anesthesiologist or nurse anesthetist and will be recorded upon diagnosis of condition for all groups. | Evaluation of these complications will be done from the point the patient has returned to the recovery room to up to one week post-surgery or until discharge, whichever comes first. | |
Secondary | Patient Awareness during Anesthesia | Patient awareness of being under anesthesia will be recorded qualitatively, with accounts of anxiety and/or fear being noted, if applicable. | This measure will be evaluated up to 48 hours post-surgical operation. | |
Secondary | Incidence of Nightmare during Use | Patient's report of experiencing nightmares during the surgery will be recorded qualitatively. | This measure will be evaluated up to 48 hours post-surgical operation. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03421548 -
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
|
N/A | |
Recruiting |
NCT05694247 -
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
|
N/A | |
Terminated |
NCT04485858 -
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat KPro for the Treatment of Corneal Blindness
|
N/A | |
Recruiting |
NCT02948023 -
Stem Cells Therapy for Corneal Blindness
|
Phase 1 |